About: Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 29 July 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Juli 2020 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2020 (ast) scientific article published on 29 July 2020 (en) 2020 ജൂലൈ 29-ന് പ്രസിദ്ധീകരിച്ച ശാസ്ത്രീയ ലേഖനം (ml) наукова стаття, опублікована 29 липня 2020 (uk)
publication date	wds:Q99238561-DDF962D5-F8D5-4A9D-A09B-9C04E15B8F2F
publication date	2020-07-29 00:00:00Z (xsd:dateTime)
cites work	wds:Q99238561-00C6538D-1299-4038-9089-2660A35AC5C8 wds:Q99238561-095AC522-EE8C-4A79-8F7D-9F8D754F201C wds:Q99238561-0EECE74F-2FB1-4A3B-9CE3-BDD27051ACD0 wds:Q99238561-21664AD2-9B9A-4C08-8AF7-E5365B011E4B wds:Q99238561-25549CAF-C8E1-4493-9076-27004A5751F3 wds:Q99238561-2ACBB661-DFB3-40D1-A834-3B7A442B4537 wds:Q99238561-30DB93C1-E8C1-4FB5-B093-ACB0682FB6EF wds:Q99238561-3B851847-25E2-4EAA-A16E-F6086878BA6E wds:Q99238561-474ADB9E-6023-44A4-9D93-F120A02A2EA7 wds:Q99238561-66435271-64D2-4EBE-AD9E-EA37176CF40E wds:Q99238561-6C607C63-F382-458B-AE6F-C768CB0DEC4E wds:Q99238561-736BA619-CDF4-4DE2-9170-E87CE8C46972 wds:Q99238561-78D2A265-CEB3-4906-8931-D241EE94463D wds:Q99238561-79F6B5DD-F191-4BEE-9DE6-AB9D8417DFE3 wds:Q99238561-91F406A8-E4E2-405D-A7CF-9259BD2D4525 wds:Q99238561-99C96B76-B3EC-4321-B6EA-C344CA11FB7E wds:Q99238561-9A39296E-F5E9-4740-8E22-51C8508CA5F0 wds:Q99238561-A53952A4-9A2E-43AB-A773-C31FCCEC79B7 wds:Q99238561-A62239A0-D4B3-4F08-B1E5-9D47A31B680A wds:Q99238561-AA80B616-4F15-4A2E-AE50-567F30209555 wds:Q99238561-B2CE4BA3-EF86-45B0-958D-DBC4BA9A41BA wds:Q99238561-B34C59DB-A42F-41BD-B8BF-45BF9579F2DC wds:Q99238561-B65EA132-0244-42BC-8402-1D5B7CA2FB25 wds:Q99238561-B771D1BC-51CB-40D7-BCCC-0EF03BA86778 wds:Q99238561-BFAEF421-B1DE-40C4-8EF6-F5DA503956F3 wds:Q99238561-C00E2162-43B6-4CFE-A7D6-529E7439E11F wds:Q99238561-C3BD9D5F-5927-4DF0-A05A-1C91FD978701 wds:Q99238561-CF3D2CB8-DDC3-4D24-92BC-DC4B301D2659 wds:Q99238561-D3DD8952-6BF6-41CC-8264-469B7E7BAF0C wds:Q99238561-DA7EAF9E-A884-46D1-826C-59129366219B wds:Q99238561-E385D49B-EE67-4C52-BF4D-A5422BF573BC wds:Q99238561-EA19DCE8-AFD3-4060-9F3E-B5891CC21E86 wds:Q99238561-F2D4FE86-66FF-43D5-B28E-DE2C299F095C wds:Q99238561-F404217B-D7B5-424E-A3AB-AA391E2D7311
cites work	Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters Rapid stable isotope dilution analysis of very-long-chain fatty acids, pristanic acid and phytanic acid using gas chromatography-electron impact mass spectrometry Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia. Peroxisomes, lipid metabolism and lipotoxicity. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes Lovastatin in X-linked adrenoleukodystrophy Human disorders of peroxisome metabolism and biogenesis Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history Adrenoleukodystrophy: clinical and biochemical manifestations in carriers ACBD5 deficiency causes a defect in peroxisomal very long-chain fatty acid metabolism. Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man Simultaneous quantitation of hexacosanoyl lysophosphatidylcholine, amino acids, acylcarnitines, and succinylacetone during FIA-ESI-MS/MS analysis of dried blood spot extracts for newborn screening Newborn Screening for X-Linked Adrenoleukodystrophy Disease progression in women with X-linked adrenoleukodystrophy is slow Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders. Comparison of C26:0-carnitine and C26:0-lysophosphatidylcholine as diagnostic markers in dried blood spots from newborns and patients with adrenoleukodystrophy. Peanut consumption increases levels of plasma very long chain fatty acids in humans Increased very long chain fatty acids in patients on a ketogenic diet: a cause of diagnostic confusion Very long-chain fatty acids in erythrocyte membrane phospholipids in adrenoleukodystrophy Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor
author name string	wds:Q99238561-2454A119-9D96-4658-98CB-3EA25DB0B2FB wds:Q99238561-24FEB716-716D-45BA-B2A8-F2361E46CEAD wds:Q99238561-49E99471-E73A-45F5-A103-A9D1EDC8DE72 wds:Q99238561-6FD5D171-78D4-4554-A6B5-41D508D86E78 wds:Q99238561-887B2E41-CB0D-48AF-AE4C-4FD18C1F175D wds:Q99238561-92D52771-30D3-4FC0-A72A-C8E7BC953148 wds:Q99238561-BB50DBE8-BE8D-4184-8D30-8B0478820D2F wds:Q99238561-CB8F91ED-1349-471F-AC60-D70043EA255A wds:Q99238561-CF4446B2-A302-4F5C-8033-5EAA3781CEC3
author name string	Frédéric M Vaz Marc Engelen Stephan Kemp Susan M I Goorden Wim Kulik Henk van Lenthe Inge M E Dijkstra Yorrick R J Jaspers Rinse Willem Barendsen
rdfs:label	Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders (en) Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders (nl)
skos:prefLabel	Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders (en) Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders (nl)
name	Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal Disorders (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software